We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+9.67%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$98.6B
AUM Growth
+$9.82B
Cap. Flow
+$3.18B
Cap. Flow %
3.23%
Top 10 Hldgs %
34.51%
Holding
3,532
New
899
Increased
935
Reduced
953
Closed
698

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$3.93B
2
MSFT icon
Microsoft
MSFT
+$556M
3
COR icon
Cencora
COR
+$492M
4
NFLX icon
Netflix
NFLX
+$452M
5
BAC icon
Bank of America
BAC
+$411M

Sector Composition

Rank Sector Weight
1 Technology 20.19%
2 Consumer Discretionary 12.64%
3 Healthcare 9.35%
4 Financials 8.34%
5 Communication Services 6.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BAER icon
2426
Bridger Aerospace
BAER
$109M
$283K ﹤0.01%
153,192
-24,031
-14% -$45.6K
DHX icon
2427
DHI Group
DHX
$177M
$282K ﹤0.01%
+101,341
New +$280K
INFA
2428
DELISTED
Informatica
INFA
$281K ﹤0.01%
+11,300
New +$279K
SAND
2429
DELISTED
Sandstorm Gold
SAND
$280K ﹤0.01%
+22,400
New +$238K
ORLY icon
2430
CALL
O'Reilly Automotive
ORLY
$75.1B
$280K ﹤0.01%
+2,600
New +$261K
UPST icon
2431
PUT
Upstart Holdings
UPST
$2.55B
$279K ﹤0.01%
+5,500
New +$387K
APGE icon
2432
Apogee Therapeutics
APGE
$10.1B
$279K ﹤0.01%
7,027
-83,541
-92% -$3.19M
AM icon
2433
Antero Midstream
AM
$10.2B
$277K ﹤0.01%
14,228
-466,077
-97% -$8.42M
MGNI icon
2434
Magnite
MGNI
$2.83B
$275K ﹤0.01%
+12,648
New +$299K
CSIQ icon
2435
Canadian Solar
CSIQ
$932M
$274K ﹤0.01%
+21,028
New +$252K
RGR icon
2436
Sturm, Ruger & Co
RGR
$603M
$274K ﹤0.01%
+6,300
New +$227K
INDI icon
2437
indie Semiconductor
INDI
$636M
$274K ﹤0.01%
67,258
-183,577
-73% -$757K
ONL
2438
Orion Office REIT
ONL
$151M
$273K ﹤0.01%
+100,959
New +$270K
LSBK icon
2439
Lake Shore Bancorp
LSBK
$135M
$272K ﹤0.01%
+20,910
New +$281K
IDT icon
2440
IDT Corp
IDT
$1.67B
$272K ﹤0.01%
5,196
-89,478
-95% -$5.58M
WB icon
2441
Weibo
WB
$1.97B
$271K ﹤0.01%
21,884
-240,658
-92% -$2.63M
CCRN
2442
DELISTED
Cross Country Healthcare
CCRN
$271K ﹤0.01%
19,100
-29,551
-61% -$390K
ACRV icon
2443
Acrivon Therapeutics
ACRV
$61.2M
$271K ﹤0.01%
149,715
-31,472
-17% -$44.2K
XGN icon
2444
Exagen
XGN
$105M
$271K ﹤0.01%
+24,632
New +$218K
NSP icon
2445
Insperity
NSP
$2.03B
$269K ﹤0.01%
+5,476
New +$300K
AIT icon
2446
Applied Industrial Technologies
AIT
$12.4B
$269K ﹤0.01%
+1,032
New +$271K
DMAC icon
2447
DiaMedica Therapeutics
DMAC
$341M
$268K ﹤0.01%
39,062
-22,657
-37% -$123K
UXIN
2448
Uxin Ltd
UXIN
$306M
$268K ﹤0.01%
+77,339
New +$296K
HOFT icon
2449
Hooker Furnishings Corp
HOFT
$147M
$267K ﹤0.01%
26,354
-20,413
-44% -$213K
FET icon
2450
Forum Energy Technologies
FET
$578M
$264K ﹤0.01%
+9,877
New +$228K

Similar funds

Marshall Wace's Q3 2025 Portfolio in Review

As of Q3 2025, Marshall Wace held 3,532 positions worth $98.6B, up 11% from $88.8B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Marshall Wace deployed $3.18B of net new capital in Q3 2025, opening 899 new positions and adding to 935 existing holdings. Its largest new stake was Texas Instruments: 1,537,539 shares worth $282M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $636M trimmed.

  • Marshall Wace's largest Q3 2025 buy was Texas Instruments: 1,537,539 shares worth $282M.
  • Marshall Wace added most to iShares Core S&P 500 ETF in Q3 2025, an estimated $3.93B increase.
  • Marshall Wace's biggest Q3 2025 reduction was Alphabet (Google) Class A, cutting an estimated $636M.
  • Marshall Wace fully exited AT&T in Q3 2025, selling an estimated $235M.
  • Marshall Wace's ten largest holdings make up 35% of its $98.6B portfolio in Q3 2025.
  • Marshall Wace opened 899 new positions and closed 698 in Q3 2025.
  • Marshall Wace's portfolio value rose 11% quarter-over-quarter to $98.6B.

Based on Marshall Wace's 13F filing for Q3 2025, filed 13 Nov 2025.